Novavax (NVAX) Stock Price, Quote, News & History | Benzinga

Novavax Inc (NVAX) Stock Price, Quote, News & History

NVAXNASDAQ

Trade with Public

Trade with Public

$9.05

-0.16-1.74%

At close: Aug 27, 5:00 PM EST

$9.02

-0.03-0.33%

After Hours: 7:45 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$9.12

Close

$9.05

Volume / Avg.

3.43M / 4.28M

Day Range

$8.91 - $9.18

52 Wk Range

6.20 - 11.97

Market Cap

$1.49B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

28.98%

Days to Cover

14.03

Recent Novavax, Inc. News

QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax

FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk conditions.

Benzinga News-desk

Novavax Stock Rallies Tuesday: What's Happening?

Shares of Novavax are trading higher Tuesday morning as buying interest continues across late-stage vaccine developers.

Henry Khederian

Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why

Recursion, Novavax and Crispr Therapeutics slip in premarket trading after surging Wednesday on positive cancer therapy trial results.

Mohd Haider

Novavax Stock Moves Higher Wednesday: What's Driving the Action?

Shares of Novavax Inc (NASDAQ: NVAX) are trading higher Wednesday. The move comes as a major clinical victory in the oncology space generated widespread momentum across vaccine developers.

Henry Khederian

Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb

Moderna and Novavax stocks climb as investors digest new cases in the hantavirus outbreak.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-36.90M

Investing Cash Flow (TTM)

-109.51M

Financing Cash Flow (TTM)

74.71M

Free Cash Flow (TTM)

-43.03M

Capital Expenditure (TTM)

-6.12M

Net Change in Cash (TTM)

-71.70M

Analyst Trends and Forecast

0

0

0

0

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.07B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.64

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-16.91%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$1.16

Company Debt

Total Debt

$291.49M

LT Debt

$291.49M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$8.36M

Total Cash

$191.46M

Debt to Equity

-

Issuance of Debt (TTM)

$34.24M

Repayment of Debt (TTM)

-$8.36M

Key Statistics

Open

$9.12

Close

$9.05

Volume / Avg.

3.43M / 4.28M

Day Range

$8.91 - $9.18

52 Wk Range

6.20 - 11.97

Market Cap

$1.49B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

57

Short Interest

28.98%

Days to Cover

14.03

About

Sector

Health Care

Industry

Biotechnology

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish su...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Novavax (NVAX) stock?

A

You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Novavax (NVAX) competitors?

A

Other companies in Novavax’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Novavax (NVAX) stock?

A

Novavax has a consensus price target of $12.92.

Q

What is the current price for Novavax (NVAX)?

A

The stock price for Novavax (NASDAQ: NVAX) is $9.02 last updated August 27, 2026 at 7:45 PM EDT.

Q

Does Novavax (NVAX) pay a dividend?

A

There are no upcoming dividends for Novavax.

Q

When is Novavax (NASDAQ:NVAX) reporting earnings?

A

Novavax does not have any upcoming earnings scheduled.

Q

Is Novavax (NVAX) going to split?

A

There is no upcoming split for Novavax.

Q

What sector and industry does Novavax (NVAX) operate in?

A

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.